Skip to main content
The Journal of Veterinary Medical Science logoLink to The Journal of Veterinary Medical Science
. 2026 Jul 22;88(10):1479–1481. doi: 10.1292/jvms.26-0247

Frequencies of the SERPINF2 c.605C>T variant implicated in delayed postoperative hemorrhage among dog breeds at a single referral center in Japan

Haruhiko MARUYAMA 1,*, Nanako OZAKI 1, Kumi KATO 1, Saki NISHIMURA 1
PMCID: PMC13680701  PMID: 42486646

Abstract

Delayed postoperative hemorrhage (DEPOH) is recognized in sighthound breeds and has been associated with a SERPINF2 c.605C>T variant that affects alpha-2-antiplasmin, an important inhibitor of fibrinolysis. The distribution of this variant among dogs in Japan has not been investigated. To determine the frequency of the SERPINF2 c.605C>T variant in dogs presented to a single referral hospital in Japan. Genomic DNA was extracted from peripheral blood of dogs presented to the Animal Medical Center of Nihon University between July 2021 and October 2022. Genotyping of SERPINF2 c.605C>T variant was performed by real-time PCR using a TaqMan minor groove binder SNP genotyping assay. Adequate amplification was obtained in 433 of 436 samples. Homozygous variant genotypes (T/T) were detected in one Italian Greyhound, one Whippet, and two Shiba Inu dogs. Heterozygous genotypes (C/T) were detected in Saluki, Italian Greyhound, Shiba Inu, French Bulldog, mixed-breed dog, Boston Terrier, Jack Russell Terrier, and Chihuahua. Among non-sighthound breeds, Shiba Inu dogs had the highest observed variant allele frequency in this cohort (0.25). The DEPOH-associated SERPINF2 c.605C>T variant was detected in both sighthound and non-sighthound dogs in this Japanese referral-hospital cohort. The relatively high allele frequency observed in Shiba Inu dogs warrants further multicenter studies evaluating variant frequency and its relationship with clinical DEPOH.

Keywords: alpha-2-antiplasmin, delayed postoperative hemorrhage, fibrinolysis, SERPINF2, Shiba Inu

INTRODUCTION

Delayed postoperative hemorrhage (DEPOH) is characterized by delayed bleeding after surgery and has been recognized most commonly in sighthound breeds, including Greyhounds, Scottish Deerhounds and Irish Wolfhound (OMIA: 002631-9615) [4, 5, 8, 9]. In Greyhounds undergoing routine gonadectomy, abnormal bleeding is typically absent during surgery and in the immediate postoperative period, but hemorrhagic signs such as peri-incisional ecchymosis may develop 36 to 48 hr after surgery [8]. Severe cases in Greyhounds have been reported to require blood component therapy and intensive care [2]. The syndrome is not considered to result primarily from platelet dysfunction or coagulation factor deficiency; instead, impaired clot maintenance or increased clot fragility has been suggested [8, 14, 15]. Prophylactic administration of the antifibrinolytic drug epsilon-aminocaproic acid has been reported to reduce delayed postoperative bleeding in Greyhounds [10, 11]. However, DEPOH cannot be reliably predicted by routine coagulation assays or screening tests for primary hemostasis [8]. Consequently, recognition of this disorder may be particularly difficult in breeds that are not traditionally considered sighthounds.

Alpha-2-antiplasmin (A2AP), also known as alpha-2-plasmin inhibitor, is a serine protease inhibitor produced primarily in the liver [12, 16]. By inhibiting plasmin, A2AP stabilizes fibrin thrombi and limits excessive fibrinolysis. Congenital A2AP abnormalities can therefore result in excessive fibrinolytic activity and a bleeding tendency [1]. The gene encoding A2AP is SERPINF2 [7], and several pathogenic SERPINF2 variants have been reported in human A2AP deficiency, in which homozygous individuals typically present with severe bleeding symptoms, whereas heterozygous individuals may show a mild bleeding tendency or be asymptomatic [3, 6]. In dogs, the SERPINF2 c.605C>T variant has been identified in association with DEPOH in Scottish Deerhounds [5]. Compared with wild-type dogs, reported bleeding risk is markedly increased in Scottish Deerhounds carrying this variant, particularly in dogs homozygous for the T allele. Detection of this variant has therefore been proposed as a useful biomarker for DEPOH in Scottish deerhounds [5].

A recent survey of SERPINF2 c.605C>T across dog breeds in the United States showed that the variant is not restricted to sighthound breeds and is also present in several non-sighthound breeds [4]. In Japan, however, reports of DEPOH in dogs are lacking, and the distribution of this variant among dogs has not been investigated. The objective of the present study was to determine the frequency of the SERPINF2 c.605C>T variant in dogs presented to a single referral hospital in Japan using real-time PCR with TaqMan minor groove binder (MGB) probes.

MATERIALS AND METHODS

Animals and DNA samples

Dogs presented for an initial visit to the Animal Medical Center of Nihon University between July 2021 and October 2022, regardless of disease, were included. Genomic DNA was extracted from the residual cellular fraction remaining after separation of sodium citrate-anticoagulated plasma submitted for coagulation testing. DNA extraction was performed using NucleoSpin Blood QuickPure (TaKaRa Bio Inc., Kusatsu, Japan) or MagExtractor -Genome- (TOYOBO Co., Ltd., Osaka, Japan). The study was approved by the review committee of the Animal Medical Center of Nihon University (approval number: 3-006). Breed classification as sighthound or non-sighthound was based on the report by Court et al. [4] and the American Kennel Club list of sighthound breeds (https://www.akc.org/expert-advice/dog-breeds/meet-sighthound-breeds/).

Genotyping

Genotyping was performed using real-time PCR with a TaqMan MGB SNP Genotyping Assay (Applied Biosystems, Thermo Fisher Scientific). Primers and TaqMan MGB probes were designed and synthesized by Thermo Fisher Scientific using CanFam4 (UU_Cfam_GSD_1.0) as the reference sequence and the SERPINF2 variant information reported by Court et al. [4, 5]. The primer and probe sequences are shown in Table 1.

Table 1. Primers and TaqMan minor groove binder probes used for genotyping of the canine SERPINF2 c.605C>T variant.

Oligonucleotide Sequence Final concentration (nM)
Forward primer 5′-ACGCTGCGGAGGTTAGAGC-3′ 480
Reverse primer 5′-CCCAGGTCCTGGCAAAGG-3′ 480
Wild-type allele MGB probe 5′-VIC-CCAGAGTCTGCATGCAG-MGB-3′ 200
Variant allele MGB probe 5′-FAM-CCAGAGTCTACATGCAG-MGB-3′ 200

VIC, VIC reporter dye; FAM, 6-carboxyfluorescein. The underlined nucleotide indicates the allele-discriminating base at the SERPINF2 c.605C>T site. Final concentrations indicate those used in the PCR reaction.

Plasmid controls containing the wild-type and variant alleles were prepared by amplifying a 461-bp SERPINF2 region from genomic DNA of an Italian Greyhound heterozygous for the SERPINF2 c.605C>T variant using the following primers: 5′-TGTCACCCCAATCAGTTTAGTG-3′ and 5′-AGTCCTCTTTGATGGGAAATCC-3′. The PCR products were cloned into a TA-cloning vector, and plasmids carrying each allele were identified by Sanger sequencing. These plasmids were used as homozygous wild-type and homozygous variant controls for the TaqMan genotyping assay. Water, PCR Grade (Roche Diagnostics GmbH, Mannheim, Germany), was used as the no-template negative control.

Real-time PCR was performed using the primers, TaqMan MGB probes, extracted genomic DNA, and TaqPath ProAmp Master Mix on a Thermal Cycler Dice Real Time System Lite (Takara Bio Inc.). Prepared PCR mixtures were held at 60°C for 30 sec before amplification. Cycling conditions consisted of 95°C for 5 min, followed by 40 cycles of 95°C for 15 sec and 62°C for 60 sec. A post-PCR holding stage was performed at 60°C for 30 sec. Data were analyzed using Thermal Cycler Dice Real Time System Software version 5.11C for TP700.

In addition, genomic DNA samples identified as heterozygous or homozygous for the variant by real-time PCR were subjected to conventional PCR using the same primers used for plasmid control preparation. The nucleotide sequences of the amplified PCR products were confirmed by Sanger sequencing.

RESULTS

Samples and assay performance

Genomic DNA was obtained from 436 blood samples. Genotyping by real-time PCR yielded amplification adequate for analysis in 433 dogs. Three samples did not amplify sufficiently and could not be analyzed. Although the genomic DNA concentrations of the three samples were comparable to those of successfully amplified samples, the cause of amplification failure was not determined. For all samples identified as heterozygous or homozygous for the variant by real-time PCR, the genotyping results were concordant with those obtained by Sanger sequencing.

Genotype distribution

Homozygous for the SERPINF2 c.605C >T variant (T/T) were detected in both sighthound and non-sighthound breeds. Among sighthounds, T/T genotypes were identified in one Italian Greyhound (1/2, 50.0%) and one Whippet (1/1, 100%). Among non-sighthounds, T/T genotypes were identified only in Shiba Inu dogs (2/28, 7.1%).

Heterozygous genotypes (C/T) were identified in one Saluki (1/1, 100%) and one Italian Greyhound (1/2, 50.0%) among sighthounds. Among non-sighthounds, C/T genotypes were identified in Shiba Inu dogs (10/28, 35.7%), French Bulldogs (4/18, 22.2%), mixed-breed dogs (2/53, 3.8%), Boston Terriers (1/7, 14.3%), Jack Russell Terriers (1/7, 14.3%), and Chihuahuas (1/51, 2.0%). Genotype results and variant allele frequencies in breeds carrying the T allele are summarized in Table 2.

Table 2. Genotype distribution and variant allele frequency of the canine SERPINF2 c.605C>T variant in breeds carrying the T allele.

Breed No. of dogs genotyped Genotype c.605C>T Variant allele frequency

Wild-type (C/C) Homozygous variant (T/T) Heterozygous (C/T)



No. % No. % No. %
Shiba Inu 28 16 57.1 2 7.1 10 35.7 0.25
Italian Greyhound 2 0 0.0 1 50.0 1 50.0 0.75
Whippet 1 0 0.0 1 100.0 0 0.0 1.00
French Bulldog 18 14 77.8 0 0.0 4 22.2 0.11
Mixed breed 53 51 96.2 0 0.0 2 3.8 0.02
Saluki 1 0 0.0 0 0.0 1 100.0 0.50
Boston Terrier 7 6 85.7 0 0.0 1 14.3 0.07
Jack Russell Terrier 7 6 85.7 0 0.0 1 14.3 0.07
Chihuahua 51 50 98.0 0 0.0 1 2.0 0.01

No variant allele was detected in the remaining sighthounds, consisting of one Borzoi and one Afghan Hound. Among non-sighthounds, no variant allele was detected in Toy Poodles (n=68), Miniature Dachshunds (n=37), Yorkshire Terriers (n=16), Miniature Schnauzers (n=14), Shih Tzus (n=12), Pomeranians (n=11), Cavalier King Charles Spaniels (n=10), Pembroke Welsh Corgis (n=8), Golden Retrievers and Papillons (n=7 each), Border Collies and Maltese dogs (n=6 each), Kaninchen Dachshunds and Labrador Retrievers (n=5 each), Pekingese, Beagles, Pugs, and Siberian Huskies (n=4 each), Bernese Mountain Dogs, West Highland White Terriers, and Bichon Frises (n=3 each), Shetland Sheepdogs, Standard Poodles, and Norfolk Terriers (n=2 each), and Cairn Terrier, Bolognese, American Cocker Spaniel, Australian Labradoodle, Flat-Coated Retriever, English Cocker Spaniel, Medium Poodle, Newfoundland, Labradoodle, Kai Ken, Goldendoodle, Miniature Pinscher, Saint Bernard, Schipperke, Portuguese Water Dog, Spitz, Weimaraner, Tibetan Terrier, White Swiss Shepherd Dog, and Japanese Chin (n=1 each).

DISCUSSION

This study provides the first survey, to our knowledge, of the DEPOH-associated SERPINF2 c.605C>T variant among dogs in Japan. The variant was detected in expected sighthound breeds and, importantly, in several non-sighthound breeds. The most notable finding was the relatively high variant allele frequency in Shiba Inu dogs (0.25), a non-sighthound breed. The present findings indicate that, in Japan, this variant is carried by non-sighthound breeds in addition to sighthound breeds, as has been reported in the United States [4].

Of the 28 Shiba Inu dogs examined in the present study, two were homozygous and 10 were heterozygous for the SERPINF2 c.605C>T variant. The observed allele frequency of 0.25 was similar to frequencies previously reported in Whippets and Scottish Deerhounds, breeds considered to have moderate variant allele frequencies among sighthounds [4]. It was also higher than the frequency reported in Shetland Sheepdogs, which were the non-sighthound breed with the highest frequency in the previous study [4]. In Scottish Deerhounds, the SERPINF2 c.605C>T variant has been associated with a markedly increased risk of DEPOH, although not all heterozygous dogs develop clinical bleeding [5]. Because the present study evaluated genotype only and did not assess clinical signs of DEPOH, plasma A2AP antigen concentration, or A2AP activity, the clinical significance of this variant in Shiba Inu dogs remains unknown. Larger studies that include postoperative clinical outcome data are needed before the variant can be used to infer DEPOH risk in this breed.

A relatively high frequency of the SERPINF2 c.605C>T variant was observed in Shiba Inu dogs in this cohort. However, information on relatedness among the Shiba Inu dogs examined and their breeding backgrounds was not available, and the study was conducted at a single institution. Therefore, the possibility cannot be excluded that the observed variant frequency was influenced by the inclusion of Shiba Inu dogs derived from specific lineages or breeding populations. Future studies should include a broader population of Shiba Inu dogs sampled from throughout Japan and incorporate information on relatedness and breeding background to more accurately estimate the frequency of this variant in the breed.

Several differences from the previous study conducted in the United States were observed in the present study [4]. Although the SERPINF2 c.605C>T variant was not detected in Chihuahuas in the previous study, one of the 51 Chihuahuas examined in the present study was heterozygous. Jack Russell Terriers were not included in the previous study, whereas one of seven Jack Russell Terriers in the present study was heterozygous. In addition, compared with that in the United States, the pet dog population in Japan has been reported to be more concentrated among a limited number of popular breeds, with small breeds accounting for a significant proportion [13]. Therefore, further surveys of this variant in Japan may be warranted to provide clinically useful information for veterinary practice in Japan.

The present study has several limitations. First, it was designed as a genotyping survey and did not evaluate DEPOH as a clinical phenotype. This was because the dogs included in this cohort were patients presented to a referral hospital and had various underlying diseases, which could confound assessment of bleeding phenotype or plasma A2AP measurements. Second, this was a single-center study, and many breeds were represented by only one or a few dogs. Therefore, the results should not be interpreted as precise breed-level prevalence estimates, particularly for breeds with small sample sizes. Third, because the cohort was derived from a referral hospital, it may not represent the general dog population in Japan. In addition, information regarding relatedness among individuals and breeding background was not available. Therefore, the independence of samples, particularly within breeds, could not be fully confirmed. The relatively high observed allele frequency in Shiba Inu dogs may have been influenced by related individuals or dogs from specific breeding populations. Multicenter studies including healthy dogs, larger breed-specific sample sizes, and postoperative clinical sign data will be required to determine the clinical relevance of SERPINF2 c.605C>T in Japan.

In conclusion, the SERPINF2 c.605C>T variant was identified in both sighthound and non-sighthound dogs in this Japanese referral-hospital cohort. Shiba Inu dogs showed a relatively high observed variant allele frequency, despite being a non-sighthound breed. Further studies evaluating larger numbers of Shiba Inu dogs and other breeds, together with clinical assessment of DEPOH, may improve understanding of the pathophysiology, diagnosis, and risk stratification of delayed postoperative hemorrhage in dogs.

Conflicts of Interest

The authors declare no conflicts of interest.

REFERENCES

  • 1.Abdul S, Leebeek FW, Rijken DC, Uitte de Willige S. 2016. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences. Blood 127: 538–545. doi: 10.1182/blood-2015-09-670117 [DOI] [PubMed] [Google Scholar]
  • 2.Birkbeck R, Humm K, Cortellini S. 2019. A review of hyperfibrinolysis in cats and dogs. J Small Anim Pract 60: 641–655. doi: 10.1111/jsap.13068 [DOI] [PubMed] [Google Scholar]
  • 3.Carpenter SL, Mathew P. 2008. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance. Haemophilia 14: 1250–1254. doi: 10.1111/j.1365-2516.2008.01766.x [DOI] [PubMed] [Google Scholar]
  • 4.Court MH, Hardy M, Forbes KR, Yang H, Jimenez TP. 2025. Delayed postoperative hemorrhage (DEPOH) in an Irish Wolfhound with the SERPINF2 c.605 T/T genotype: case description and variant prevalence across dog breeds. Front Vet Sci 12: 1609780. doi: 10.3389/fvets.2025.1609780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Court MH, Kiser JN, Neibergs HL, Zhu Z, Dillberger JE. 2023. Identification by whole genome sequencing of genes associated with delayed postoperative hemorrhage in Scottish deerhounds. J Vet Intern Med 37: 510–517. doi: 10.1111/jvim.16643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Franchini M, Zaffanello M, Mannucci PM. 2021. Bleeding disorders in primary fibrinolysis. Int J Mol Sci 22: 7027. doi: 10.3390/ijms22137027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hirosawa S, Nakamura Y, Miura O, Sumi Y, Aoki N. 1988. Organization of the human alpha 2-plasmin inhibitor gene. Proc Natl Acad Sci USA 85: 6836–6840. doi: 10.1073/pnas.85.18.6836 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lara-García A, Couto CG, Iazbik MC, Brooks MB. 2008. Postoperative bleeding in retired racing greyhounds. J Vet Intern Med 22: 525–533. doi: 10.1111/j.1939-1676.2008.0088.x [DOI] [PubMed] [Google Scholar]
  • 9.Lord LK, Yaissle JE, Marin L, Couto CG. 2007. Results of a web-based health survey of retired racing Greyhounds. J Vet Intern Med 21: 1243–1250. doi: 10.1111/j.1939-1676.2007.tb01945.x [DOI] [PubMed] [Google Scholar]
  • 10.Marín LM, Iazbik MC, Zaldivar-Lopez S, Guillaumin J, McLoughlin MA, Couto CG. 2012. Epsilon aminocaproic acid for the prevention of delayed postoperative bleeding in retired racing greyhounds undergoing gonadectomy. Vet Surg 41: 594–603. doi: 10.1111/j.1532-950X.2012.00965.x [DOI] [PubMed] [Google Scholar]
  • 11.Marín LM, Iazbik MC, Zaldivar-Lopez S, Lord LK, Stingle N, Vilar P, Lara-Garcia A, Alvarez F, Hosoya K, Nelson L, Pozzi A, Cooper E, McLoughlin MA, Ball R, Kisseberth WC, London CA, Dudley R, Dyce J, McMahon M, Lerche P, Bednarski R, Couto CG. 2012. Retrospective evaluation of the effectiveness of epsilon aminocaproic acid for the prevention of postamputation bleeding in retired racing Greyhounds with appendicular bone tumors: 46 cases (2003–2008). J Vet Emerg Crit Care (San Antonio) 22: 332–340. doi: 10.1111/j.1476-4431.2012.00735.x [DOI] [PubMed] [Google Scholar]
  • 12.Moroi M, Aoki N. 1976. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 251: 5956–5965. doi: 10.1016/S0021-9258(17)33045-4 [DOI] [PubMed] [Google Scholar]
  • 13.Nagasawa M, Kanbayashi S, Mogi K, Serpell JA, Kikusui T. 2016. Comparison of behavioral characteristics of dogs in the United States and Japan. J Vet Med Sci 78: 231–238. doi: 10.1292/jvms.15-0253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Saavedra PV, Stingle N, Iazbik C, Marín L, McLoughlin MA, Xie Y, Couto G. 2011. Thromboelastographic changes after gonadectomy in retired racing greyhounds. Vet Rec 169: 99. doi: 10.1136/vr.d2671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vilar P, Couto CG, Westendorf N, Iazbik C, Charske J, Marín L. 2008. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 22: 374–379. doi: 10.1111/j.1939-1676.2008.0061.x [DOI] [PubMed] [Google Scholar]
  • 16.Wiman B, Collen D. 1977. Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma. Eur J Biochem 78: 19–26. doi: 10.1111/j.1432-1033.1977.tb11709.x [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Veterinary Medical Science are provided here courtesy of Japanese Society of Veterinary Science

RESOURCES